Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dobber JA"'
Autor:
Gromme, M, Russcher, Henk, Braakman, Eric, Klinkspoor, JH, Dobber, JA, Greef, Georgine, de Wit, NCJ
Publikováno v:
Transfusion, 57(8), 1949-1955. Wiley-Blackwell
Transfusion, 57(8), 1949-1955. Wiley
Transfusion, 57(8), 1949-1955. Wiley-Blackwell Publishing Ltd
Transfusion, 57(8), 1949-1955. Wiley
Transfusion, 57(8), 1949-1955. Wiley-Blackwell Publishing Ltd
BACKGROUNDCD: 34 flow cytometry is the gold standard for stem cell enumeration in peripheral blood at the mobilization stage and in the final apheresis product. The new stem cell mode of the Sysmex XN Series analyzer enumerates an immature cell popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::08a843f54882d2d6c0a9e6f81a9477cf
https://pure.amc.nl/en/publications/multicenter-study-to-evaluate-a-new-enumeration-method-for-hematopoietic-stem-cell-collection-management(53790950-49c7-4bf6-9d92-0d32b2c25f4e).html
https://pure.amc.nl/en/publications/multicenter-study-to-evaluate-a-new-enumeration-method-for-hematopoietic-stem-cell-collection-management(53790950-49c7-4bf6-9d92-0d32b2c25f4e).html
Autor:
van der Straten L; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam-Treatment and Quality of Life, Amsterdam, The Netherlands., Kersting S; Department of Hematology, HAGA Teaching Hospital, The Hague, The Netherlands., Nasserinejad K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dubois J; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Dobber JA; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Mellink CHM; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Kevie-Kersemaekers AF; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands., Evers LM; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Koene HR; Department of Hematology, Antonius Hospital, Nieuwegein, The Netherlands., Schreurs J; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Velders GA; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands., van der Straaten HM; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, The Netherlands., Hoogendoorn M; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., van Gelder M; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier The Graaf Hospital, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Visser HPJ; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands., Houtenbos I; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., Idink CAM; Department of Internal Medicine, ZorgSaam Hospital, Terneuzen, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, s-Hertogenbosch, The Netherlands., Dompeling EC; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., van Zaanen HCT; Department of Internal Medicine, St Franciscus Hospital, Rotterdam, The Netherlands., Veelken JH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Levenga H; Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands., Tick LW; Department of Internal Medicine, Maxima Medical Center, Eindhoven, The Netherlands., Terpstra WE; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Langerak AW; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Publikováno v:
Blood [Blood] 2023 Sep 28; Vol. 142 (13), pp. 1131-1142.
Autor:
Hengeveld PJ; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Schilperoord-Vermeulen J; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., van der Klift MY; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Dubois JMN; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Kolijn PM; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Kavelaars FG; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rijken M; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Dobber JA; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Kersting S; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Kater AP; Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Langerak AW; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. m-d.levin@asz.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Jul 04; Vol. 13 (1), pp. 102. Date of Electronic Publication: 2023 Jul 04.
Autor:
Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands. Electronic address: a.p.kater@amsterdamumc.nl., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., Dubois J; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Kersting S; Department of Hematology, Haga Hospital, Den Haag, Netherlands., Enggaard L; Department of Hematology, Herlev Hospital, Copenhagen, Denmark., Veldhuis GJ; Department of Hematology, St Antonius Hospital, Sneek, Netherlands., Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., Mellink CHM; Department of Human Genetics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., van der Kevie-Kersemaekers AF; Department of Human Genetics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Dobber JA; Laboratory of Special Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Poulsen CB; Department of Hematology, Zealand University Hospital, Roskilde, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Janssens A; Department of Hematology, UZ Leuven, Leuven, Belgium., Schjødt I; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Dompeling EC; Department of Hematology, Isala Ziekenhuis, Zwolle, Netherlands., Ranti J; Department of Hematology, Turku University Central Hospital, Turku, Finland., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Mattsson M; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Bellido M; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Tran HTT; Department of Hematology, Akershus University Hospital, Lørenskog, Norway., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: carsten.utoft.niemann@regionh.dk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jun; Vol. 23 (6), pp. 818-828.
Autor:
Amaador K; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Vos JMI; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Pals ST; Department of Pathology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Kraan W; Department of Pathology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dobber JA; Laboratory of Hematology, Amsterdam UMC, Amsterdam, The Netherlands., Minnema MC; Department of Hematology, University Medical Center, University Utrecht, Utrecht, The Netherlands., Koene HR; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands., de Bruin PC; Department of Pathology, St. Antonius Hospital, Nieuwegein, The Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam and LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1070-1079. Date of Electronic Publication: 2021 Dec 27.
Autor:
Kersting S; Department of Hematology, HAGA Teaching Hospital, The Hague, Netherlands. Electronic address: s.kersting@hagaziekenhuis.nl., Dubois J; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, Netherlands., Nasserinejad K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Dobber JA; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands., Mellink C; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, Netherlands., van der Kevie-Kersemaekers AF; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, Netherlands., Evers LM; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, Netherlands., Koene HR; Department of Hematology, Antonius Hospital, Nieuwegein, Netherlands., Schreurs J; Department of Internal Medicine, Martini Hospital, Groningen, Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, Netherlands., Velders GA; Department of Internal Medicine, Gelderland Valley Hospital, Ede, Netherlands., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, Netherlands., van der Straaten HM; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, Netherlands., Hoogendoorn M; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, Netherlands., van Gelder M; Department of Hematology, MUMC, Maastricht, Netherlands., Posthuma EFM; Department of Internal Medicine, RDGG, Delft, Netherlands., Visser HPJ; Department of Internal Medicine, Northwest Clinics, Alkmaar, Netherlands., Houtenbos I; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, Netherlands., Idink CAM; Department of Internal Medicine, ZorgSaam hospital, Terneuzen, Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch hospital, 's-Hertogenbosch, Netherlands., Dompeling EC; Department of Hematology, Isala Hospital, Zwolle, Netherlands., van Zaanen HCT; Department of Internal Medicine, St Franciscus Hospital, Rotterdam, Netherlands., Veelken H; Department of Hematology, LUMC, Leiden, Netherlands., Levenga H; Department of Internal Medicine, Groene Harthospital, Gouda, Netherlands., Tick LW; Department of Internal Medicine, Maxima MC, Eindhoven, Netherlands., Terpstra WE; Department of Internal Medicine, OLVG, Amsterdam, Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, Netherlands., Boyer M; Roche Products Limited, Welwyn Garden City, UK., Mobasher M; Genentech, South San Francisco, CA, USA., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, Netherlands.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2022 Mar; Vol. 9 (3), pp. e190-e199.
Autor:
Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Dubois J; Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands., Kersting S; Department of Hematology, Haga Ziekenhuis, Den Haag, The Netherlands., Enggaard L; Department of Hematology, Herlev Hospital, Copenhagen, Denmark., Veldhuis GJ; Department of Hematology, Antonius Ziekenhuis, Sneek, The Netherlands., Mous R; Department of Hematology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Mellink CHM; Department of Clinical Genetics and., Dobber JA; Laboratory of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Poulsen CB; Department of Hematology, Roskilde University Hospital, Roskilde, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Janssens A; Department of Hematology, Universitair Ziekenhuis Leuven, Leuven, Belgium., Schjødt I; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Dompeling EC; Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands., Ranti J; Department of Hematology, Turku University Central Hospital, Turku, Finland., Mattsson M; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Bellido M; Department of Hematology, UMC Groningen, University of Groningen, Groningen, The Netherlands., Tran HTT; Department of Hematology, Akershus University Hospital, Lørenskog, Norway; and., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood [Blood] 2021 Feb 25; Vol. 137 (8), pp. 1117-1120.
Autor:
Svanberg R; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark., Ostrowski SR; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Nasserinejad K; Erasmus MC Cancer Centre, HOVON Data Center, Clinical Trial Center, Rotterdam, Netherlands., Kersting S; Department of Hematology, HagaZiekenhuis, Den Haag, Netherlands., Dobber JA; Laboratory of Hematology, Amsterdam University Medical Centres, Amsterdam, Netherlands., Mattson M; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Tran HTT; Department of Hematology, Akershus University Hospital, Lorenskog, Norway., Levin MD; Department of Internal medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands., Mous R; Department of Hematology, UMC Utrecht Cancer Center, Utrecht, Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Centres, Amsterdam, Netherlands., Niemann CU; Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark.; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Dec; Vol. 61 (14), pp. 3422-3431. Date of Electronic Publication: 2020 Aug 31.
Autor:
Saberi Hosnijeh F; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands. Electronic address: f.saberihosnijeh@erasmusmc.nl., van der Straten L; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands., Posthuma WFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Chamuleau MED; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Bellido M; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Gelder M; Department of Hematology, University Medical Center, Maastricht, The Netherlands., Hoogendoorn M; Department of Internal Medicine, Medical Center, Leeuwarden, The Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Te Raa GD; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands., Kerst JM; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Marijt EWA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Raymakers RAP; Department of Hematology, University Medical Center, Utrecht, The Netherlands., Koene HR; Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands., Schaafsma MR; Department of Hematology, Medical Spectrum Twente, Enschede, The Netherlands., Dobber JA; Laboratory Special Hematology, Academic Medical Center, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kersting SS; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Langerak AW; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Publikováno v:
Experimental hematology [Exp Hematol] 2020 Sep; Vol. 89, pp. 55-60.e6. Date of Electronic Publication: 2020 Aug 08.
Autor:
de Weerdt I; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Hofland T; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Boer R; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Dobber JA; Department of Hematology, Cancer Center Amsterdam, and., Dubois J; Department of Hematology, Cancer Center Amsterdam, and., van Nieuwenhuize D; Department of Hematology, Cancer Center Amsterdam, and.; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Mobasher M; Genentech Inc., South San Francisco, CA., de Boer F; Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Hoogendoorn M; Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Velders GA; Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands., van der Klift M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Remmerswaal EBM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bemelman FJ; Renal Transplant Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Niemann CU; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kersting S; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands; and., Eldering E; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Cancer Center Amsterdam, and.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands., Kater AP; Department of Hematology, Cancer Center Amsterdam, and.; Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2019 Sep 10; Vol. 3 (17), pp. 2642-2652.